Business Description
GC Biopharma Corp. is a South Korean biopharmaceutical company, founded in 1967 and based in Yongin-Si, that develops and sells a broad range of medical treatments both domestically and abroad. Its product lineup spans everyday pain relief and anti-inflammatory patches, blood-related therapies for conditions such as hemophilia and hepatitis B, vaccines, and treatments for rare diseases including Hunter syndrome and liver cancer. The company is also working with Novelty Nobility to develop new antibody-based treatments for geographic atrophy, a serious eye condition. GC Biopharma operates as part of the larger Green Cross Holdings Corporation.
